Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Non Operating Income (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Non Operating Income for 5 consecutive years, with -$1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 1228.87% to -$1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$880000.0, a 131.76% decrease, with the full-year FY2024 number at $3.1 million, up 369.61% from a year prior.
  • Non Operating Income was -$1.1 million for Q3 2025 at Werewolf Therapeutics, down from $11000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.7 million in Q2 2024 to a low of -$1.1 million in Q3 2025.
  • A 5-year average of $318894.7 and a median of $17000.0 in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: soared 13086.67% in 2022, then crashed 9700.0% in 2025.
  • Werewolf Therapeutics' Non Operating Income stood at $15000.0 in 2021, then skyrocketed by 13086.67% to $2.0 million in 2022, then tumbled by 100.3% to -$6000.0 in 2023, then soared by 5133.33% to $302000.0 in 2024, then tumbled by 462.58% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Non Operating Income are -$1.1 million (Q3 2025), $11000.0 (Q2 2025), and -$98000.0 (Q1 2025).